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Arthropathies (FIHOA), quality of life evaluated by the SF12, psycholog-
ical impact of disease by the Hamilton Anxiety Depression scale (HAD),
and the number of radiologically affected joints. Statistics: mean [standard
deviation (sd)]; Kruskall test for univariate analysis of correlations and
multiple regression analysis.
Results: 101 patients were studied: 90% women (93% menopaused),
10% men, mean age 63.8 (8.7), BMI 23.4 (3.4), 63% with a familial history
of HOA, mean symptoms duration 10 (7.5) years. Aesthetic damage
scored 43.2 (37.7) mm. It was scored 11.6 (25.6) by men and 46.9 (37.2)
by women. Univariate analysis identiﬁed the following possible clinically
correlated parameters: gender (p = 0.002); the number of painful joints on
pressure (Spearman r: 0.30; p = 0.007); n. of radiologically affected joints
(r: 0.26; p = 0.01); n. of spontaneously painful joints (r: 0.23; p = 0.05);
and a trend for the n. of nodal joints (r:0.18; p = 0.08). No correlation was
found for pain at rest or on activity, FIHOA, SF12, HAD. Results of the
multivariate analysis are in the table.




N. of painful joints on pressure 4.9 (2.0) [1.0; 8.8] 0.01
Sex 31.9 (14.5) [3.5; 60.3] 0.03
N. of affected joints on X-rays 0.7 (1.3) [−1.8; 3.2] 0.60
N. of painful joints 4.2 (3.1) [−1.8;
10.3]
0.17
N. of nodal joints −1.4 (2.0) [−5.2; 2.5] 0.49
FIHOA 0.5 (0.9) [−1.2; 2.3] 0.56
HAD depression 1.2 (1.6) [−2.0; 4.3] 0.47
Conclusions: This study highlights for the ﬁrst time that aesthetic
damage is a major concern for HOA patients. Aesthetic damage was
independant from pain VAS and functional impairment but signiﬁcantly
correlated with female gender and surprisingly the number of painful joints
on pressure. Interestingly no association was found with depression.
This issue should deserve more attention and a speciﬁc tool exploring
aesthetic damage in hand OA and its dimensions should be developed.
295 ISOKINETIC TORQUE AND FUNCTIONAL CAPACITY IN
WOMEN WITH AND WITHOUT OSTEOARTHRITIS OF THE
KNEE
V. Bayrakci Tunay, G. Baltaci, I. Duzgun, D. Ozer. Hacettepe University,
Ankara, TURKEY
Purpose: Osteoarthritis (OA) of the knee causes pain and loss of joint
mobility which leads to restriction in physical functioning: patients can no
longer walk as far or fast. The purpose of this study was to compare the
isokinetic strength measurements of the quadriceps and hamstring and
functional outcomes in patients with knee osteoarthritis (OA) and healthy
subjects.
Methods: A total of 159 volunteer subjects, 60 patients (mean
age: 52.31±8.73 years) with bilateral knee OA and 99 age-matched
(50.79±7.77 years) healthy subjects participated in the study. Isokinetic
peak torque (PT) measurements of the knee extensors and ﬂexors at
180º/sec (ISOMED 2000), timed performance test (timed up&go) (TUG)
for functional capacity, and body composition analyse (TANITA) for body
weight, body mass index (BMI) and fat percent were used.
Results: The healthy subjects demonstrated greater differences in ﬂexor
isokinetic torques and TUG test results than the OA group (right knee
ﬂexor PT; t = −5.05, p = 0.0, left knee ﬂexor PT; t = −6.5, p = 0.0, TUG
test; t = 6.01, p = 0.0). Participants in both groups demonstrated similar
results and no signiﬁcance in extensor PT values of the knees (right
knee extensor PT; t = −1.05, p = 0.29, left knee extensor PT; t = −1.05,
p = 0.29). In body composition analyse healthy subjects’ body weights and
BMI found greater than the OA group (body weight: t = −2.12, p = 0.035,
BMI: t = −3.55, p = 0.001).
Conclusions: Quadriceps muscle strength and weight differences may
not be the most important indicators in the knee OA. To improve agonist-
antagonist muscle balance of the quadriceps and hamstring muscle may
be the most important than focused on only strengthening the quadriceps
muscle in rehabilitation.
296 HOW CLINICAL OUTCOMES MAY BE INFLUENCED BY THE
NUMBER OF AFFECTED JOINTS IN HAND OA (HOA)?
E. Maheu, M. Michon, F. Carrat, F. Berenbaum. St Antoine Hospital,
Paris, FRANCE
Purpose: Objectives: To look at the relationship between the number of
clinically or radiologically affected joints and clinical parameters in HOA.
Methods: Prospective cross-sectional study. Successive outpatients visit-
ing at the Hand OA clinic of St-Antoine hospital were examined according
to a standardized case report form. Postero-anterior X-rays of both
hands on a single ﬁlm were performed. Data collected: demographics,
personal/familial medical history, HOA history, clinical and radiological
description, including nodes, pain at rest and on move (VAS), pain on
joint pressure, patient’s global disease assessment, aesthetic damage
scored by patients on a 0–100mm VAS, function (Functional Index for
Hand Arthropathies (FIHOA)), quality of life (SF12), psychological impact
of HOA (Hamilton Anxiety Depression (HAD) scale) and the number of
affected joints on X-rays. Statistics: %, mean [standard deviation (sd)];
Spearman correlation coefﬁcient was used to assess correlations.
Results: 101 patients were studied: 90% women (93% on menopause),
10% men, mean age 63.8 (8.7), BMI 23.4 (3.4), 63% with a familial
history of HOA, mean symptoms duration 10 (7.5) years. Mean scores
were 48.3 (25.4) mm for pain during activity, 43.2 (37.7) mm for aesthetic
damage, 41.4 (27.7) mm for patients global assessment, 8.2 (6.0) for
FIHOA [0−30], 6.6 (3.3) for HAD scale [0−21], 44.7 (7.2) for SF12 [0–
100].
Results of the correlations between the numbers of affected joints and
clinical outcomes are in the table.
Table. Correlations between the number of HOA joints affected and clinical outcomes
Variable r; P N of spontaneous
painful joints
N of painful joints
on pressure
N nodal joints N radiologically
affected joints
Pain at rest 0.07; 0.53 0.22; 0.06 0.01; 0.90 0.05; 0.63
Pain on activity 0.05; 0.66 0.33; 0.003 0.05; 0.60 0.22; 0.04
Aesthetic damage 0.23; 0.05 0.30; 0.007 0.18; 0.08 0.26; 0.01
Patients global −0.03; 0.80 0.38; 0.001 −0.07; 0.52 0.18; 0.09
FIHOA 0.17; 0.16 0.30; 0.01 0.04; 0.72 0.17; 0.11
SF12 MCS 0.04; 0.77 −0.14; 0.22 0.02; 0.83 0.06; 0.59
SF12 PCS −0.17; 0.17 −0.28; 0.02 0.03; 0.79 −0.13; 0.25
SF12 total −0.09; 0.46 −0.23; 0.05 0.008; 0.93 −0.06; 0.58
HAD depression −0.08; 0.50 0.13; 0.28 0.03; 0.78 0.08; 0.44
HAD anxiety 0.11; 0.34 0.21; 0.07 0.08; 0.43 0.15; 0.16
HAD total 0.01; 0.93 0.17; 0.13 0.05; 0.61 0.13; 0.21
In addition, no correlation between night awakening and the number of
affected joints was observed. Conversely, morning stiffness was signif-
icantly correlated to the number of painful joints (p = 0.05), the number
of nodal joints (p = 0.01) and the number of affected joints on X-rays
(p 0.006).
Conclusions: The number of radiologically affected joints is correlated
to pain on activity, aesthetic damage and morning stiffness in HOA
patients. Moreover, the number of painful joints on pressure is signiﬁcantly
associated with a higher score of all clinical parameters but morning
stiffness.
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Foundation, Vail, CO, USA
Purpose: The purpose of this study was to determine patients’ expecta-
tion of treatment and document outcomes following treatment protocol in
which corticosteroid is used, in addition to initial Synvisc injection 3 series.
Methods: 63 patients were enrolled in a prospective cohort study, IRB
approved with informed patient consent. Inclusion criteria were patients
aged 18−80 years with knee osteoarthritis diagnosis based on radio-
graphic examination (Kellgren-Lawrence). Patients with prior synovec-
tomy on injection knee were excluded, as well as if they had rheuma-
toid disease, any serious systemic disease, acute synovitis, excessive
effusion, allergy to avian products/hyaluronan-based injection compo-
nents/corticosteroid injection, pregnant, previous arthroscopic surgery
within last 6 months or joint infection within previous 3 months. Patients
were given standard course of 3 (2ml) weekly injections. At ﬁrst injection,
in addition to Hylan G-F 20, corticosteroid was added, but not in second
and third. At 3, 6 and 12 weeks and 6 months following injection series
completion, patients completed a form with WOMAC score. Patients
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completed SF-12 at preinjection and 6 months and an expectations
questionnaire prior to surgery. 20 patient expectation domains were
measured and analyzed individually, as “very important” to “of little to
no importance”.
17 patients dropped out due to non-medical reasons. Of 46 remaining, 27
were female, 18 male. Average age was 65 (range 42−81). 30 patients
(65%) reported previous knee surgery.
Results: All patients reported pain as reason for seeking medical treat-
ment. Pain relief was very important to only 66% of patients and some-
what important to 12%. If patients expected pain relief, 43% expected
most pain to be relieved. 36% expected all pain to be relieved. 17 (37%)
reported stiffness as primary reason for seeking medical treatment. Only
54% of patients expected knee stiffness/swelling to stop. Improving ability
to walk was considered very important in 89% and they expected to walk
more than 1 mile. 80% of patients considered return to recreational sports
an important expectation and somewhat important in 13%. The most
important expectation in this group was to have conﬁdence in their knee,
avoid future knee degeneration and improve ability to maintain general
health. All patients rated these important. Getting knee back to where it
was before problem started was only important in 66% of patients.
No patient discontinued injection series due to negative response to
injection. 3 (7%) required surgery prior to 6 month time-point. All 3 had
previous knee surgery. Average age of failures was 68 (range 66−70).
In the 43 patients, results showed positive response in initial weeks
following completion of injection series (Figure). Patients at 6 months
showed signiﬁcant improvement in pain, WOMAC score, Lysholm and
SF-12 physical component.
Pre-injection 6 months p-value
Lysholm 40 62 0.001
WOMAC Pain 7 5 0.004
WOMAC Total 28 23 0.047
SF-12 PCS 41 45 0.015
SF-12 MCS 57 58 0.795
Conclusions: In these patients, regaining function was the most im-
portant expectation for injection treatment. Improving ability to walk and
returning to recreational activity showed to be more important to patients
than reducing symptoms. Although patients had higher expectations for
improvement in knee function, Hylan G-F 20 with corticosteroid, showed
to signiﬁcantly improve function, and signiﬁcantly decrease pain. Hylan
G-F 20 and corticosteroid may be a good treatment option for older
patients suffering from osteoarthritis, who desire to return to an active
lifestyle.
298 IMPROVING THE SAFETY AND EFFECTIVENESS OF
INTRA-ARTICULAR PROCEDURES: A RANDOMIZED
CONTROLLED TRIAL OF THE RECIPROCATING
PROCEDURE DEVICE
P.A. Band1, W.L. Sibbitt Jr.2, A.A. Michael2, R.R. Sibbitt3,
A.D. Bankhurst2. 1New York University School of Medicine, New
York, NY, USA, 2University of New Mexico Health Sciences Center,
Albuquerque, NM, USA, 3St Peters Hospital, Helena, MT, USA
Purpose: The potential for intra-articular treatments to improve the med-
ical management of osteoarthritis (OA) continues to receive increasing
attention, particularly for patients in whom one or two problem joints drive
their disability. To improve the procedure for administering intra-articular
therapies, a new syringe-like device was speciﬁcally designed for mus-
culoskeletal aspiration/injection procedures. Termed the Reciprocating
Procedure Device (RPD), this device enables signiﬁcantly more precise
control of needle position, reduces procedure pain and trauma, increases
the volume of synovial ﬂuid that can be collected, and decreases the
time for performing intra-articular procedures (Arthritis & Rheumatism, in
press). These attributes are important for both therapy and biomarker
analysis. Corticosteroid and hyaluronan are the agents most commonly
administered by intra-articular injection, both of which require precise
delivery of the agent to the anatomical intra-articular space. In this trial
we hypothesized that the outcome of local therapy for OA was dependent
on the needle placement and needle control characteristics of the device
used for arthrocentesis and injection.
Methods: One hundred patients with symptomatic OA in a single large
joint were enrolled in an IRB-approved protocol, registered at clinical-
trials.gov. Patients were randomized to have arthrocentesis and intra-
articular corticosteroid injection performed using either the RPD or a
conventional syringe. The primary outcome measure was pain in the
affected joint, measured (1) at baseline (prior to the procedure), (2) during
local anesthesia, (3) during the arthrocentesis/injection procedure itself,
(4) at 2 weeks post-procedure, and (5) at 6 months post-procedure. Pain
was measured using a Visual Analogue Pain Scale (VAPS) (0 = no pain,
10 =most severe pain) with signiﬁcant pain being deﬁned as a VAPS
score >5.
Results: The group randomized to the RPD experienced signiﬁcantly
reduced pain scores during both local anesthesia administration (Syringe:
6.75±2.51; RPD: 3.63±1.98, p< 0.001), and during the arthrocente-
sis/injection procedure (Syringe: 4.25±2.51; RPD 2.54±1.98, p< 0.001).
With respect to longer term treatment outcomes, the RPD was signif-
icantly more effective than the conventional syringe in reducing pain
scores at 2 weeks (Syringe: 3.27±3.41; RPD: 1.89±0.98, p< 0.001),
the time point at which corticosteroid injections are expected to exhibit
their greatest efﬁcacy. Pain scores at 6 months trended toward improved
effectiveness for the RPD group (Syringe: 6.67±2.41; RPD: 4.89±2.98,
p = 0.06).
Conclusions: Though both groups experience the therapeutic beneﬁt
expected from intra-articular corticosteroid injection, this study demon-
strates that the device used to administer intra-articular therapy can inﬂu-
ence the safety and effectiveness of the procedure itself. Moreover, the
data demonstrate that the RPD signiﬁcantly improves patient outcomes
at two weeks post-injection, and suggests the potential for improved
therapeutic outcomes at six months. Considering the growing importance
of ofﬁce-based intra-articular procedures to OA treatment, the utility of the
RPD to substantially improve patient safety, comfort and outcomes should
be conﬁrmed in additional studies.
299 KNEE INJURY AND OSTEOARTHRITIS OUTCOME SCORE
(KOOS) AND CARTILAGE BIOMARKERS IN MIDDLE-AGED
WOMEN WITH EARLY OSTEOARTHRITIS (OA)
A.E. TAMM1, J. Kumm1, M. Lintrop1, B-C. Sondergaard2, A.O. Tamm1.
1University of Tartu, Tartu, ESTONIA, 2Nordic Bioscience Diagnostics,
Harlev, DENMARK
Purpose: In comparison with WOMAC, the novel self-reported quanti-
tative index Knee Injury and Osteoarthritis Outcome Score (KOOS) has
two new subscales Sport/Recreation (SP/Rec) and Quality of Life (QL).
Recently the short form KOOS-PS was published (Perruccio et al 2008)
which focuses on some components of SP/Rec. There is evidence that
intensive turnover of collage type II takes place in early OA.
Aim: To investigate the associations of the functional limitations ex-
pressed by KOOS with emphasis on the Sp/Rec subscale with (i) ra-
diographic features of early KOA, (ii) degradation of type II collagen
and (iii) low-level inﬂammation in middle-aged women at baseline and
at 3 years.
Methods: A subset of women, including 100 subjects aged 34−54 years
(mean 45) at baseline, from a representative symptomatic cohort of Elva,
South-Estonia, was followed up. BMI> 26 was observed in 66% of the
women.
KOOS: The KOOS questionnaire includes the following subscales: Symp-
toms (S), Pain (P), Activities of daily life (ADL), Sport/recreation (SP/Rec)
and Quality of life (QL). An index value was calculated for every subscale
(0–100; better functional status is expressed by higher index value).
Radiographs: Antero-posterior weight-bearing radiographs of the tibio-
femoral compartment (TF) and axial radiographs of the patello-femoral
(PF) compartment of the knee joint were assessed.
